Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples